<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">47003</article-id><article-id pub-id-type="doi">10.7554/eLife.47003</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Reducing RSV hospitalisation in a lower-income country by vaccinating mothers-to-be and their households</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-135215"><name><surname>Brand</surname><given-names>Samuel PC</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0645-5367</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146857"><name><surname>Munywoki</surname><given-names>Patrick</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9419-7155</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146858"><name><surname>Walumbe</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19302"><name><surname>Keeling</surname><given-names>Matthew J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146859"><name><surname>Nokes</surname><given-names>David James</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5426-1984</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">The Zeeman Institute (SBIDER), School of Life Sciences</institution>, <institution>University of Warwick</institution>, <addr-line><named-content content-type="city">Coventry</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Virus Epidemiology and Control Group</institution>, <institution>KEMRI-Wellcome Trust Research Centre</institution>, <addr-line><named-content content-type="city">Kilifi</named-content></addr-line>, <country>Kenya</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-8518"><name><surname>Akhmanova</surname><given-names>Anna</given-names></name><role>Reviewing editor</role><aff><institution>Utrecht University</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>S.Brand@warwick.ac.uk</email> (SB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>03</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e47003</elocation-id><history><date date-type="received"><day>19</day><month>03</month><year>2019</year></date><date date-type="accepted"><day>26</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Brand et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Brand et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-47003-v1.pdf"/><abstract><p>Respiratory syncytial virus is the leading cause of lower respiratory tract infection among infants. RSV is a priority for vaccine development. In this study, we investigate the potential effectiveness of a two-vaccine strategy aimed at mothers-to-be, thereby boosting maternally acquired antibodies of infants, and their household cohabitants, further cocooning infants against infection. We use a dynamic RSV transmission model which captures transmission both within households and communities, adapted to the changing demographics and RSV seasonality of a low-income country. Model parameters were inferred from past RSV hospitalisations, and forecasts made over a 10-year horizon. We find that a 50% reduction in RSV hospitalisations is possible if the maternal vaccine effectiveness can achieve 75 days of additional protection for newborns combined with a 75% coverage of their birth household co-inhabitants (∼7.5% population coverage).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>The Wellcome Trust</institution></institution-wrap></funding-source><award-id>102975</award-id><principal-award-recipient><name><surname>Nokes</surname><given-names>David James</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript, supporting files or on the cited Github Repository. Source data files have been provided for Figures 2-6.</p></sec><supplementary-material><ext-link xlink:href="elife-47003-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>